SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005864
Filing Date
2017-08-03
Accepted
2017-08-03 16:56:39
Documents
95
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20170630x10q.htm 10-Q 2455936
2 EX-31.1 irwd-20170630ex311e4bfa0.htm EX-31.1 18560
3 EX-31.2 irwd-20170630ex312546d68.htm EX-31.2 18509
4 EX-32.1 irwd-20170630ex321767de8.htm EX-32.1 8489
5 EX-32.2 irwd-20170630ex322676314.htm EX-32.2 8625
  Complete submission text file 0001558370-17-005864.txt   9990836

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20170630.xml EX-101.INS 2180795
7 EX-101.SCH irwd-20170630.xsd EX-101.SCH 75772
8 EX-101.CAL irwd-20170630_cal.xml EX-101.CAL 82164
9 EX-101.DEF irwd-20170630_def.xml EX-101.DEF 417176
10 EX-101.LAB irwd-20170630_lab.xml EX-101.LAB 620463
11 EX-101.PRE irwd-20170630_pre.xml EX-101.PRE 624487
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 171005800
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences